<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/4753</identifier>
				<datestamp>2020-02-15T08:42:16Z</datestamp>
				<setSpec>aabp:RS3</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Fetal Protection Against Continuous Exposure To Bovine Viral Diarrhea Virus Following Administration of A Vaccine Containing an Inactivated BVDV Fraction</dc:title>
	<dc:creator xml:lang="en">Grooms, Daniel L.</dc:creator>
	<dc:creator xml:lang="en">Bolin, Steven R.</dc:creator>
	<dc:creator xml:lang="en">Coe, Paul H.</dc:creator>
	<dc:creator xml:lang="en">Borges, Rafael</dc:creator>
	<dc:creator xml:lang="en">Coutu, Christopher E.</dc:creator>
	<dc:subject xml:lang="en">Bovine viral diarrhea virus</dc:subject>
	<dc:subject xml:lang="en">BVDV</dc:subject>
	<dc:subject xml:lang="en">economic loss</dc:subject>
	<dc:subject xml:lang="en">persistent infection</dc:subject>
	<dc:subject xml:lang="en">viremia</dc:subject>
	<dc:subject xml:lang="en">fetal infection</dc:subject>
	<dc:description xml:lang="en">Bovine viral diarrhea virus (BVDV) is a major viral pathogen of cattle, leading to substantial economic losses. A major source of loss is attributed to fetal infection with subsequent fetal pathology. The major source of virus transmission is cattle that are immunotolerant and persistently infected with BVDV. The objective of this study was to determine if a commercially available killed BVDV vaccine (CattleMasterR® Gold TM FP™ L5, Pfizer Animal Health) could protect cattle against viremia and fetal infection during continuous exposure to cattle persistently infected with the BVDV. This type of model may more closely represent natural challenge, including continuous exposure to multiple virus strains.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2006-09-21</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/4753</dc:identifier>
	<dc:identifier>10.21423/aabppro20064753</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; 2006; 266</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/4753/4650</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2006 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
